Search Results - "HALMOS, G"

Refine Results
  1. 1
  2. 2

    Treatment of keratinocyte carcinoma in elderly patients – a review of the current literature by Leus, A.J.G., Frie, M., Haisma, M.S., Terra, J.B., Plaat, B.E.C., Steenbakkers, R.J.H.M., Halmos, G.B., Rácz, E.

    “…A large percentage of the patients with keratinocyte carcinoma (KC, formerly known as non‐melanoma skin cancer) is of advanced age and often too frail for…”
    Get full text
    Journal Article
  3. 3

    Evaluation of a new two-step frailty assessment of head and neck patients in a prospective cohort by Padovan, Beniamino Vincenzoni, Bijl, M. A. J., Langendijk, J. A., van der Laan, H. P., Van Dijk, B. A. C., Festen, S., Halmos, G. B.

    Published in European archives of oto-rhino-laryngology (01-08-2024)
    “…Purpose Assessing frailty, in head and neck cancer (HNC) patients is key when choosing appropriate treatment. Optimal screening is challenging, as it should be…”
    Get full text
    Journal Article
  4. 4

    Incidental findings during the diagnostic work-up in the head and neck cancer pathway: Effects on treatment delay and survival by Schoonbeek, R.C., Bult, F.F.S., Plaat, B.E.C., Witjes, M.J.H., van der Hoorn, A., van Dijk, B.A.C., Halmos, G.B.

    Published in Oral oncology (01-07-2021)
    “…•Incidental findings (IFs) are present in 61.5% of head and neck cancer patients.•Relevant IFs (21.6%) result in significant delay in treatment initiation.•The…”
    Get full text
    Journal Article
  5. 5

    A comparison of the Thunderbeat and standard electrocautery devices in head and neck surgery: a prospective randomized controlled trial by Kuipers, N. C., de Kleijn, B. J., Wedman, J., van der Laan, B. F. A. M., Plaat, B. E. C., Halmos, G. B.

    Published in European archives of oto-rhino-laryngology (01-12-2021)
    “…Purpose New energy-based sutureless vessel ligation devices, such as the Thunderbeat (Olympus Medical Systems Corp., Tokyo, Japan), could reduce operative time…”
    Get full text
    Journal Article
  6. 6

    Treatment in elderly patients with head and neck cancer: A challenging dilemma by Teymoortash, A., Ferlito, A., Halmos, G. B.

    Published in HNO (01-04-2016)
    “…Despite the increasing number of elderly patients requiring treatment for head and neck cancer, there is insufficient available evidence about the oncological…”
    Get full text
    Journal Article
  7. 7

    Age‐specific incidence and treatment patterns of head and neck cancer in the Netherlands—A cohort study by Halmos, G.B., Bras, L., Siesling, S., Laan, B.F.A.M., Langendijk, J.A., Dijk, B.A.C.

    Published in Clinical otolaryngology (01-02-2018)
    “…Objectives To explore the incidence and treatment pattern of head and neck cancer in different age groups. Design Cohort study. Setting Netherlands Cancer…”
    Get full text
    Journal Article
  8. 8

    Predictive value of the Groningen Frailty Indicator for treatment outcomes in elderly patients after head and neck, or skin cancer surgery in a retrospective cohort by Bras, L., Peters, T.T.A., Wedman, J., Plaat, B.E.C., Witjes, M.J.H., van Leeuwen, B.L., van der Laan, B.F.A.M., Halmos, G.B.

    Published in Clinical otolaryngology (01-10-2015)
    “…Objectives Careful selection of patients eligible for extensive head and neck cancer surgery is extremely important. A reliable predictor for postoperative…”
    Get full text
    Journal Article
  9. 9

    Clinical outcome of salvage neck dissections in head and neck cancer in relation to initial treatment, extent of surgery and patient factors by Bovenkamp, K., Noordhuis, M.G., Oosting, S.F., Laan, B.F.A.M., Roodenburg, J.L., Bijl, H.P., Halmos, G.B., Plaat, B.E.C.

    Published in Clinical otolaryngology (01-06-2017)
    “…Objective Salvage surgery has a higher complication rate compared to primary surgical treatment. We evaluated clinical outcome of salvage neck dissections in…”
    Get full text
    Journal Article
  10. 10
  11. 11

    High sensitivity and negative predictive value of sentinel lymph node biopsy in a retrospective early stage oral cavity cancer cohort in the Northern Netherlands by Boeve, K., Schepman, K.P., Schuuring, E., Roodenburg, J.L.N., Halmos, G.B., Dijk, B.A.C., Boorsma, R.A.C., Visscher, J.G.A.M., Brouwers, A.H., Vegt, B., Witjes, M.J.H.

    Published in Clinical otolaryngology (01-08-2018)
    “…Objectives In cT1‐2N0, oral squamous cell carcinoma (OSCC) occult metastases are detected in 23%‐37% of cases. Sentinel lymph node biopsy (SLNB) was introduced…”
    Get full text
    Journal Article
  12. 12

    ATP-Evoked Intracellular Ca2+ Signaling of Different Supporting Cells in the Hearing Mouse Hemicochlea by Horváth, T., Polony, G., Fekete, Á., Aller, M., Halmos, G., Lendvai, B., Heinrich, A., Sperlágh, B., Vizi, E. S., Zelles, T.

    Published in Neurochemical research (01-02-2016)
    “…Hearing and its protection is regulated by ATP-evoked Ca 2+ signaling in the supporting cells of the organ of Corti, however, the unique anatomy of the cochlea…”
    Get full text
    Journal Article
  13. 13

    Early feeding after total laryngectomy results in shorter hospital stay without increased risk of complications: a retrospective case-control study by Serbanescu-Kele, C.M.C., Halmos, G.B., Wedman, J., van der Laan, B.F.A.M., Plaat, B.E.C.

    Published in Clinical otolaryngology (01-12-2015)
    “…Objectives To evaluate the effects of a reduced nil per os (NPO) period after total laryngectomy (TLE) on general and wound‐related post‐operative…”
    Get full text
    Journal Article
  14. 14

    Hypothalamic Hormones and Cancer by Schally, Andrew V., Comaru-Schally, Ana Maria, Nagy, Attila, Kovacs, Magdolna, Szepeshazi, Karoly, Plonowski, Artur, Varga, Jozsef L., Halmos, Gabor

    Published in Frontiers in neuroendocrinology (01-10-2001)
    “…The use of peptide analogs for the therapy of various cancers is reviewed. Inhibition of the pituitary–gonadal axis forms the basis for oncological…”
    Get full text
    Journal Article
  15. 15

    The inhibitory effect of a novel cytotoxic somatostatin analogue AN-162 on experimental glioblastoma by Pozsgai, E, Schally, A V, Halmos, G, Rick, F, Bellyei, S

    Published in Hormone and metabolic research (01-10-2010)
    “…Glioblastoma multiforme is the most common and most aggressive type of high grade tumor with a poor prognosis upon discovery. Based on earlier promising…”
    Get more information
    Journal Article
  16. 16

    Incidence of unplanned oophorectomy at laparoscopic ovarian cystectomy for clinically benign cysts by Pinto, R. M., Michos, G., Papageorgiou, G., Halmos, G., Moustafa, M., Magos, A.

    Published in Journal of obstetrics and gynaecology (01-11-2014)
    “…Abstract Laparoscopic surgery is the preferred approach in women with ovarian cysts and a low risk of malignancy, and the aim in young women should be to…”
    Get full text
    Journal Article
  17. 17

    New approaches to therapy of cancers of the stomach, colon and pancreas based on peptide analogs by Schally, A V, Szepeshazi, K, Nagy, A, Comaru-Schally, A M, Halmos, G

    “…Cancers of the stomach, colon and exocrine pancreas are major international health problems and result in more than a million deaths worldwide each year. The…”
    Get full text
    Journal Article
  18. 18

    High incidence of receptors for luteinizing hormone-releasing hormone (LHRH) and LHRH receptor gene expression in human prostate cancers by Halmos, G, Arencibia, J M, Schally, A V, Davis, R, Bostwick, D G

    Published in The Journal of urology (01-02-2000)
    “…Agonistic analogs of luteinizing hormone-releasing hormone (LHRH) are widely used for therapy of advanced prostate cancer based upon their ability to suppress…”
    Get more information
    Journal Article
  19. 19

    Growth hormone-releasing hormone antagonists inhibit growth of human ovarian cancer by Papadia, A, Schally, A V, Halmos, G, Varga, J L, Seitz, S, Buchholz, S, Rick, F, Zarandi, M, Bellyei, S, Treszl, A, Szalontay, L, Lucci, J A

    Published in Hormone and metabolic research (01-10-2011)
    “…Epithelial ovarian carcinoma is the leading cause of cancer-related deaths among women with gynecologic malignancies. Antagonists of the growth…”
    Get more information
    Journal Article
  20. 20